SCC
ZVSAW

Spring Creek Capital’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Spring Creek Capital’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-262,500
Closed -$45K – 624
2022
Q1 		$45K Buy
+262,500
New +$45K ﹤0.01% 583